India's Marksans Pharma up on UK nod for drug to treat muscle spasms

Marksans Pharma

19/03/2025 07:15

** Shares of Marksans Pharma MARK.NS rise 2.6% to 208.02 rupees apiece

** Generic drug formulations maker's UK unit gets marketing authorisation for Baclofen 10 mg tablets from country's drug regulator

** Baclofen used to treat muscle spasms

** MARK shares are down 30% in 2025 so far compared to the 3.1% drop in benchmark Nifty 50 .NSEI and 9.9% fall in pharma index .NIPHARM, according to exchange data

 (Reporting by Bharath Rajeswaran in Bengaluru)

 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))